Rhinomed Limited
Rhinomed Limited (RNO.AX) Stock Competitors & Peer Comparison
See (RNO.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RNO.AX | A$0.04 | -6.98% | 11.5M | -1.00 | -A$0.04 | N/A |
| COH.AX | A$311.67 | -2.15% | 20.4B | 55.28 | A$5.65 | +1.73% |
| PNV.AX | A$1.21 | -6.20% | 853.2M | 123.50 | A$0.01 | N/A |
| EBR.AX | A$1.34 | -4.96% | 522.1M | -7.00 | -A$0.20 | N/A |
| IMR.AX | A$1.21 | -1.22% | 329.6M | -6.10 | -A$0.20 | N/A |
| AVH.AX | A$1.69 | +1.20% | 224.1M | -2.54 | -A$0.67 | N/A |
| ARX.AX | A$0.61 | -3.17% | 220.8M | -64.00 | -A$0.01 | N/A |
| AVR.AX | A$5.05 | -1.56% | 187.5M | -0.98 | -A$5.32 | N/A |
| SOM.AX | A$0.78 | -4.91% | 180.5M | -16.70 | -A$0.05 | N/A |
| EMV.AX | A$1.74 | +0.00% | 148.8M | -24.86 | -A$0.07 | N/A |
Stock Comparison
RNO.AX vs COH.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, COH.AX has a market cap of 20.4B. Regarding current trading prices, RNO.AX is priced at A$0.04, while COH.AX trades at A$311.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas COH.AX's P/E ratio is 55.28. In terms of profitability, RNO.AX's ROE is +15.91%, compared to COH.AX's ROE of +0.20%. Regarding short-term risk, RNO.AX is more volatile compared to COH.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check COH.AX's competition here
RNO.AX vs PNV.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, PNV.AX has a market cap of 853.2M. Regarding current trading prices, RNO.AX is priced at A$0.04, while PNV.AX trades at A$1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas PNV.AX's P/E ratio is 123.50. In terms of profitability, RNO.AX's ROE is +15.91%, compared to PNV.AX's ROE of +0.08%. Regarding short-term risk, RNO.AX is less volatile compared to PNV.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check PNV.AX's competition here
RNO.AX vs EBR.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, EBR.AX has a market cap of 522.1M. Regarding current trading prices, RNO.AX is priced at A$0.04, while EBR.AX trades at A$1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas EBR.AX's P/E ratio is -7.00. In terms of profitability, RNO.AX's ROE is +15.91%, compared to EBR.AX's ROE of -1.51%. Regarding short-term risk, RNO.AX is less volatile compared to EBR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check EBR.AX's competition here
RNO.AX vs IMR.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, IMR.AX has a market cap of 329.6M. Regarding current trading prices, RNO.AX is priced at A$0.04, while IMR.AX trades at A$1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas IMR.AX's P/E ratio is -6.10. In terms of profitability, RNO.AX's ROE is +15.91%, compared to IMR.AX's ROE of +4.30%. Regarding short-term risk, RNO.AX and IMR.AX have similar daily volatility (2.47).Check IMR.AX's competition here
RNO.AX vs AVH.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, AVH.AX has a market cap of 224.1M. Regarding current trading prices, RNO.AX is priced at A$0.04, while AVH.AX trades at A$1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas AVH.AX's P/E ratio is -2.54. In terms of profitability, RNO.AX's ROE is +15.91%, compared to AVH.AX's ROE of -0.40%. Regarding short-term risk, RNO.AX is less volatile compared to AVH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check AVH.AX's competition here
RNO.AX vs ARX.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, ARX.AX has a market cap of 220.8M. Regarding current trading prices, RNO.AX is priced at A$0.04, while ARX.AX trades at A$0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas ARX.AX's P/E ratio is -64.00. In terms of profitability, RNO.AX's ROE is +15.91%, compared to ARX.AX's ROE of -0.04%. Regarding short-term risk, RNO.AX is more volatile compared to ARX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check ARX.AX's competition here
RNO.AX vs AVR.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, AVR.AX has a market cap of 187.5M. Regarding current trading prices, RNO.AX is priced at A$0.04, while AVR.AX trades at A$5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas AVR.AX's P/E ratio is -0.98. In terms of profitability, RNO.AX's ROE is +15.91%, compared to AVR.AX's ROE of -2.19%. Regarding short-term risk, RNO.AX is less volatile compared to AVR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check AVR.AX's competition here
RNO.AX vs SOM.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, SOM.AX has a market cap of 180.5M. Regarding current trading prices, RNO.AX is priced at A$0.04, while SOM.AX trades at A$0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas SOM.AX's P/E ratio is -16.70. In terms of profitability, RNO.AX's ROE is +15.91%, compared to SOM.AX's ROE of -0.13%. Regarding short-term risk, RNO.AX is less volatile compared to SOM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check SOM.AX's competition here
RNO.AX vs EMV.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, EMV.AX has a market cap of 148.8M. Regarding current trading prices, RNO.AX is priced at A$0.04, while EMV.AX trades at A$1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas EMV.AX's P/E ratio is -24.86. In terms of profitability, RNO.AX's ROE is +15.91%, compared to EMV.AX's ROE of -0.36%. Regarding short-term risk, RNO.AX is less volatile compared to EMV.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check EMV.AX's competition here
RNO.AX vs 4DX.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, 4DX.AX has a market cap of 142M. Regarding current trading prices, RNO.AX is priced at A$0.04, while 4DX.AX trades at A$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas 4DX.AX's P/E ratio is -2.77. In terms of profitability, RNO.AX's ROE is +15.91%, compared to 4DX.AX's ROE of -0.60%. Regarding short-term risk, RNO.AX is less volatile compared to 4DX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check 4DX.AX's competition here
RNO.AX vs CYC.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, CYC.AX has a market cap of 115.6M. Regarding current trading prices, RNO.AX is priced at A$0.04, while CYC.AX trades at A$0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas CYC.AX's P/E ratio is -8.00. In terms of profitability, RNO.AX's ROE is +15.91%, compared to CYC.AX's ROE of -0.29%. Regarding short-term risk, RNO.AX is less volatile compared to CYC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check CYC.AX's competition here
RNO.AX vs IPD.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, IPD.AX has a market cap of 95.3M. Regarding current trading prices, RNO.AX is priced at A$0.04, while IPD.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas IPD.AX's P/E ratio is -4.70. In terms of profitability, RNO.AX's ROE is +15.91%, compared to IPD.AX's ROE of -0.58%. Regarding short-term risk, RNO.AX is more volatile compared to IPD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check IPD.AX's competition here
RNO.AX vs CMP.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, CMP.AX has a market cap of 68.2M. Regarding current trading prices, RNO.AX is priced at A$0.04, while CMP.AX trades at A$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas CMP.AX's P/E ratio is -17.75. In terms of profitability, RNO.AX's ROE is +15.91%, compared to CMP.AX's ROE of -0.09%. Regarding short-term risk, RNO.AX is less volatile compared to CMP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check CMP.AX's competition here
RNO.AX vs CSX.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, CSX.AX has a market cap of 59.9M. Regarding current trading prices, RNO.AX is priced at A$0.04, while CSX.AX trades at A$0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas CSX.AX's P/E ratio is -38.25. In terms of profitability, RNO.AX's ROE is +15.91%, compared to CSX.AX's ROE of -0.08%. Regarding short-term risk, RNO.AX is less volatile compared to CSX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check CSX.AX's competition here
RNO.AX vs MX1.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, MX1.AX has a market cap of 53.4M. Regarding current trading prices, RNO.AX is priced at A$0.04, while MX1.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas MX1.AX's P/E ratio is -4.00. In terms of profitability, RNO.AX's ROE is +15.91%, compared to MX1.AX's ROE of -1.06%. Regarding short-term risk, RNO.AX is more volatile compared to MX1.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check MX1.AX's competition here
RNO.AX vs RSH.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, RSH.AX has a market cap of 52M. Regarding current trading prices, RNO.AX is priced at A$0.04, while RSH.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas RSH.AX's P/E ratio is -3.30. In terms of profitability, RNO.AX's ROE is +15.91%, compared to RSH.AX's ROE of -2.03%. Regarding short-term risk, RNO.AX is less volatile compared to RSH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check RSH.AX's competition here
RNO.AX vs EYE.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, EYE.AX has a market cap of 41.2M. Regarding current trading prices, RNO.AX is priced at A$0.04, while EYE.AX trades at A$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas EYE.AX's P/E ratio is -3.62. In terms of profitability, RNO.AX's ROE is +15.91%, compared to EYE.AX's ROE of -0.44%. Regarding short-term risk, RNO.AX is less volatile compared to EYE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check EYE.AX's competition here
RNO.AX vs LBT.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, LBT.AX has a market cap of 29.9M. Regarding current trading prices, RNO.AX is priced at A$0.04, while LBT.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas LBT.AX's P/E ratio is -0.42. In terms of profitability, RNO.AX's ROE is +15.91%, compared to LBT.AX's ROE of -1.50%. Regarding short-term risk, RNO.AX is more volatile compared to LBT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check LBT.AX's competition here
RNO.AX vs OSL.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, OSL.AX has a market cap of 20.9M. Regarding current trading prices, RNO.AX is priced at A$0.04, while OSL.AX trades at A$1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas OSL.AX's P/E ratio is -0.62. In terms of profitability, RNO.AX's ROE is +15.91%, compared to OSL.AX's ROE of -1.97%. Regarding short-term risk, RNO.AX is more volatile compared to OSL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check OSL.AX's competition here
RNO.AX vs NTI.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, NTI.AX has a market cap of 19.9M. Regarding current trading prices, RNO.AX is priced at A$0.04, while NTI.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas NTI.AX's P/E ratio is -1.90. In terms of profitability, RNO.AX's ROE is +15.91%, compared to NTI.AX's ROE of -1.34%. Regarding short-term risk, RNO.AX is less volatile compared to NTI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check NTI.AX's competition here
RNO.AX vs CDX.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, CDX.AX has a market cap of 18.7M. Regarding current trading prices, RNO.AX is priced at A$0.04, while CDX.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas CDX.AX's P/E ratio is -0.57. In terms of profitability, RNO.AX's ROE is +15.91%, compared to CDX.AX's ROE of -2.72%. Regarding short-term risk, RNO.AX is less volatile compared to CDX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check CDX.AX's competition here
RNO.AX vs AT1.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, AT1.AX has a market cap of 15M. Regarding current trading prices, RNO.AX is priced at A$0.04, while AT1.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas AT1.AX's P/E ratio is -1.90. In terms of profitability, RNO.AX's ROE is +15.91%, compared to AT1.AX's ROE of -0.74%. Regarding short-term risk, RNO.AX is less volatile compared to AT1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check AT1.AX's competition here
RNO.AX vs CBL.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, CBL.AX has a market cap of 13.3M. Regarding current trading prices, RNO.AX is priced at A$0.04, while CBL.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas CBL.AX's P/E ratio is -1.50. In terms of profitability, RNO.AX's ROE is +15.91%, compared to CBL.AX's ROE of -1.09%. Regarding short-term risk, RNO.AX is less volatile compared to CBL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check CBL.AX's competition here
RNO.AX vs TRU.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, TRU.AX has a market cap of 12M. Regarding current trading prices, RNO.AX is priced at A$0.04, while TRU.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas TRU.AX's P/E ratio is -1.60. In terms of profitability, RNO.AX's ROE is +15.91%, compared to TRU.AX's ROE of -0.69%. Regarding short-term risk, RNO.AX is more volatile compared to TRU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check TRU.AX's competition here
RNO.AX vs HMD.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, HMD.AX has a market cap of 10.5M. Regarding current trading prices, RNO.AX is priced at A$0.04, while HMD.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas HMD.AX's P/E ratio is -1.20. In terms of profitability, RNO.AX's ROE is +15.91%, compared to HMD.AX's ROE of -2.84%. Regarding short-term risk, RNO.AX is more volatile compared to HMD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check HMD.AX's competition here
RNO.AX vs ADR.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, ADR.AX has a market cap of 9M. Regarding current trading prices, RNO.AX is priced at A$0.04, while ADR.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas ADR.AX's P/E ratio is -0.12. In terms of profitability, RNO.AX's ROE is +15.91%, compared to ADR.AX's ROE of -2.87%. Regarding short-term risk, RNO.AX is more volatile compared to ADR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check ADR.AX's competition here
RNO.AX vs IRX.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, IRX.AX has a market cap of 9M. Regarding current trading prices, RNO.AX is priced at A$0.04, while IRX.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas IRX.AX's P/E ratio is -4.20. In terms of profitability, RNO.AX's ROE is +15.91%, compared to IRX.AX's ROE of +17.09%. Regarding short-term risk, RNO.AX is less volatile compared to IRX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check IRX.AX's competition here
RNO.AX vs UBI.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, UBI.AX has a market cap of 6.6M. Regarding current trading prices, RNO.AX is priced at A$0.04, while UBI.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas UBI.AX's P/E ratio is -0.55. In terms of profitability, RNO.AX's ROE is +15.91%, compared to UBI.AX's ROE of -0.77%. Regarding short-term risk, RNO.AX is more volatile compared to UBI.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check UBI.AX's competition here
RNO.AX vs OVN.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, OVN.AX has a market cap of 4.8M. Regarding current trading prices, RNO.AX is priced at A$0.04, while OVN.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas OVN.AX's P/E ratio is -0.40. In terms of profitability, RNO.AX's ROE is +15.91%, compared to OVN.AX's ROE of -0.80%. Regarding short-term risk, RNO.AX is less volatile compared to OVN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check OVN.AX's competition here
RNO.AX vs ALT.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, ALT.AX has a market cap of 4.6M. Regarding current trading prices, RNO.AX is priced at A$0.04, while ALT.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas ALT.AX's P/E ratio is N/A. In terms of profitability, RNO.AX's ROE is +15.91%, compared to ALT.AX's ROE of -2.31%. Regarding short-term risk, RNO.AX is more volatile compared to ALT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check ALT.AX's competition here
RNO.AX vs VTI.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, VTI.AX has a market cap of 3.7M. Regarding current trading prices, RNO.AX is priced at A$0.04, while VTI.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas VTI.AX's P/E ratio is -0.55. In terms of profitability, RNO.AX's ROE is +15.91%, compared to VTI.AX's ROE of -0.57%. Regarding short-term risk, RNO.AX is more volatile compared to VTI.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check VTI.AX's competition here
RNO.AX vs AMT.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, AMT.AX has a market cap of 3.5M. Regarding current trading prices, RNO.AX is priced at A$0.04, while AMT.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas AMT.AX's P/E ratio is -1.45. In terms of profitability, RNO.AX's ROE is +15.91%, compared to AMT.AX's ROE of -11.52%. Regarding short-term risk, RNO.AX is less volatile compared to AMT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for RNO.AX.Check AMT.AX's competition here
RNO.AX vs UCM.AX Comparison August 2025
RNO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RNO.AX stands at 11.5M. In comparison, UCM.AX has a market cap of 2.9M. Regarding current trading prices, RNO.AX is priced at A$0.04, while UCM.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RNO.AX currently has a P/E ratio of -1.00, whereas UCM.AX's P/E ratio is -1.10. In terms of profitability, RNO.AX's ROE is +15.91%, compared to UCM.AX's ROE of -0.96%. Regarding short-term risk, RNO.AX is more volatile compared to UCM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for RNO.AX.Check UCM.AX's competition here